ES2194727T3 - Estructuras tridimensionales que contienen derivados del acido hialuronico obtenidos por la tecnica del antidisolvente supercritico. - Google Patents

Estructuras tridimensionales que contienen derivados del acido hialuronico obtenidos por la tecnica del antidisolvente supercritico.

Info

Publication number
ES2194727T3
ES2194727T3 ES00931057T ES00931057T ES2194727T3 ES 2194727 T3 ES2194727 T3 ES 2194727T3 ES 00931057 T ES00931057 T ES 00931057T ES 00931057 T ES00931057 T ES 00931057T ES 2194727 T3 ES2194727 T3 ES 2194727T3
Authority
ES
Spain
Prior art keywords
technique
supercritical
dimensional structures
antidisolvent
structures containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00931057T
Other languages
English (en)
Spanish (es)
Inventor
Paolo Pallado
Marco Baggio
Carbonare Maurizio Dalle
Lanfranco Callegaro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidia Farmaceutici SpA
Original Assignee
Fidia Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farmaceutici SpA filed Critical Fidia Farmaceutici SpA
Application granted granted Critical
Publication of ES2194727T3 publication Critical patent/ES2194727T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F9/00Artificial filaments or the like of other substances; Manufacture thereof; Apparatus specially adapted for the manufacture of carbon filaments
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/28Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2201/00Foams characterised by the foaming process
    • C08J2201/04Foams characterised by the foaming process characterised by the elimination of a liquid or solid component, e.g. precipitation, leaching out, evaporation
    • C08J2201/054Precipitating the polymer by adding a non-solvent or a different solvent
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2203/00Foams characterized by the expanding agent
    • C08J2203/08Supercritical fluid
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/54Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Textile Engineering (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES00931057T 1999-04-08 2000-04-06 Estructuras tridimensionales que contienen derivados del acido hialuronico obtenidos por la tecnica del antidisolvente supercritico. Expired - Lifetime ES2194727T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999PD000071A IT1306644B1 (it) 1999-04-08 1999-04-08 Strutture tridimensionali comprendenti derivati dell'acido ialuronicoottenibili mediante la tecnica antisolvente supercritico.

Publications (1)

Publication Number Publication Date
ES2194727T3 true ES2194727T3 (es) 2003-12-01

Family

ID=11392548

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00931057T Expired - Lifetime ES2194727T3 (es) 1999-04-08 2000-04-06 Estructuras tridimensionales que contienen derivados del acido hialuronico obtenidos por la tecnica del antidisolvente supercritico.

Country Status (10)

Country Link
US (1) US7087745B1 (https=)
EP (1) EP1169387B1 (https=)
JP (1) JP2002541888A (https=)
AT (1) ATE234341T1 (https=)
AU (1) AU765563B2 (https=)
CA (1) CA2369284C (https=)
DE (1) DE60001640T2 (https=)
ES (1) ES2194727T3 (https=)
IT (1) IT1306644B1 (https=)
WO (1) WO2000061675A1 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD20010032A1 (it) 2001-02-09 2002-08-09 Fidia Advanced Biopolymers Srl Innesti ingegnerizzati per la riparazione di difetti osteocondrali
RU2220729C2 (ru) * 2002-01-31 2004-01-10 Общество с ограниченной ответственностью "Научный Центр системных исследований и технологий 2000" Гелевая композиция, используемая в стоматологии
FR2850282B1 (fr) 2003-01-27 2007-04-06 Jerome Asius Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation
RU2325193C2 (ru) * 2003-04-04 2008-05-27 Бэйко Тек Лимитед Сосудистый стент
EP1773299B1 (en) * 2004-07-12 2017-07-05 Isto Technologies Inc. Tissue matrix system
US8512730B2 (en) * 2004-07-12 2013-08-20 Isto Technologies, Inc. Methods of tissue repair and compositions therefor
JP2009518132A (ja) * 2005-12-07 2009-05-07 イスト・テクノロジーズ・インコーポレイテッド 軟骨修復方法
ITPD20060219A1 (it) 2006-05-31 2007-12-01 Fidia Farmaceutici Composizioni farmaceutiche contenenti acido ialuronico solfatato nel trattamento dell'osteoartrosi
AU2009231634B2 (en) 2008-04-04 2014-05-15 University Of Utah Research Foundation Alkylated semi-synthetic glycosaminoglycosan ethers, and methods for making and using thereof
AU2009288118B2 (en) 2008-09-02 2014-12-11 Allergan, Inc. Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
CA2830933A1 (en) 2011-03-23 2012-09-27 University Of Utah Research Foundation Methods for treating or preventing urological inflammation
US10245306B2 (en) 2012-11-16 2019-04-02 Isto Technologies Ii, Llc Flexible tissue matrix and methods for joint repair
CZ2013913A3 (cs) * 2013-11-21 2015-06-03 Contipro Biotech S.R.O. Objemný nanovlákenný materiál na bázi kyseliny hyaluronové, jejích solí nebo jejich derivátů, způsob jeho přípravy, způsob jeho modifikace, modifikovaný nanovlákenný materiál, nanovlákenný útvar a jejich použití
US10179191B2 (en) 2014-10-09 2019-01-15 Isto Technologies Ii, Llc Flexible tissue matrix and methods for joint repair
CN105734604B (zh) * 2016-03-03 2017-08-25 武汉大学 一种立体复合多糖凝胶及其电化学3d打印制备方法和应用
US11337994B2 (en) 2016-09-15 2022-05-24 University Of Utah Research Foundation In situ gelling compositions for the treatment or prevention of inflammation and tissue damage
CN111228653A (zh) 2018-11-13 2020-06-05 格莱科米拉治疗公司 用电离辐射加强癌症治疗的方法
JP2019104938A (ja) * 2019-04-04 2019-06-27 イビデン株式会社 ヒアルロン酸及び/又はその塩の粉末
JP2019104937A (ja) * 2019-04-04 2019-06-27 イビデン株式会社 ヒアルロン酸及び/又はその塩の粉末
CN110423291B (zh) * 2019-09-06 2020-06-16 焦点生物医药有限公司 一种速溶透明质酸钠制备方法
WO2025072953A1 (en) * 2023-09-28 2025-04-03 University Of Massachusetts Composition for depolymerizing resins and methods of accomplishing the same

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7811306L (sv) 1978-11-01 1980-05-02 Rothman Gunnvor Antikoagulationsmedel samt sett for dess framstellning
FR2553099B1 (fr) 1983-10-11 1989-09-08 Fidia Spa Fractions d'acide hyaluronique ayant une activite pharmaceutique, procedes pour leur preparation et compositions pharmaceutiques les contenant
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
FR2584728B1 (fr) 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
IT1198449B (it) 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
DK505588D0 (da) 1988-02-26 1988-09-09 Jesper Hamburger Middel og anvendelse af samme
IT1219587B (it) 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
IT1219942B (it) 1988-05-13 1990-05-24 Fidia Farmaceutici Esteri polisaccaridici
IT1247175B (it) 1991-04-19 1994-12-12 Fidia Spa Procedimento per la purificazione di acido ialuronico e frazione di acido ialuronico puro per uso oftalmico.
IT1254704B (it) * 1991-12-18 1995-10-09 Mini Ricerca Scient Tecnolog Tessuto non tessuto essenzialmente costituito da derivati dell'acido ialuronico
IT1260148B (it) 1992-04-17 1996-03-28 Fidia Spa Impiego di preparazioni di acido ialuronico per la formazione di tessuto osseo
ITPD940054A1 (it) 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
EP0817620B1 (en) 1995-03-28 2002-01-30 Fidia Advanced Biopolymers, S.R.L. Nanospheres comprising a biocompatible polysaccharide
US5833891A (en) * 1996-10-09 1998-11-10 The University Of Kansas Methods for a particle precipitation and coating using near-critical and supercritical antisolvents
IT1287698B1 (it) 1996-08-29 1998-08-18 Fidia Advanced Biopolymers Srl Fili da sutura essenzialmente costituiti da derivati esterei dello acido ialuronico
DK0971961T3 (da) 1997-04-04 2003-03-24 Fidia Advanced Biopolymers Srl N-sulfaterede hyaluronsyreforbindelser, derivater deraf og en fremgangsmåde til deres fremstilling

Also Published As

Publication number Publication date
DE60001640D1 (de) 2003-04-17
EP1169387A1 (en) 2002-01-09
US7087745B1 (en) 2006-08-08
EP1169387B1 (en) 2003-03-12
AU765563B2 (en) 2003-09-25
IT1306644B1 (it) 2001-10-02
AU4912600A (en) 2000-11-14
ITPD990071A1 (it) 2000-10-08
ATE234341T1 (de) 2003-03-15
JP2002541888A (ja) 2002-12-10
DE60001640T2 (de) 2004-03-25
CA2369284A1 (en) 2000-10-19
WO2000061675A1 (en) 2000-10-19
CA2369284C (en) 2010-01-12

Similar Documents

Publication Publication Date Title
ES2194727T3 (es) Estructuras tridimensionales que contienen derivados del acido hialuronico obtenidos por la tecnica del antidisolvente supercritico.
BR0113663A (pt) Composições de pelìcula de pectina
Kouchak In situ gelling systems for drug delivery
PT1144459E (pt) Acidos hialuronicos reticulados e as suas utilizacoes em medicina
DE60316291D1 (de) Esterderivate von hyaluronsäure zur herstellung von hydrogelmaterialien durch photohärtung
TR200102314T2 (tr) Damar gelişimi inhibitörleri olarak kuinazolin türevleri.
BR0207760A (pt) Composição farmacêutica, uso da mesma, métodos para o tratamento de dor e de inflamação, e, processo para a preparação de uma composição
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
ES2170853T3 (es) Nanosferas que comprenden un polisacarido biocompatible.
DE69533370D1 (de) Heparinähnliche sulfatierte Polysaccharide
BR0016000A (pt) Conjunto de conexão para o campo da osteossìntese raquidiana
BR0208741A (pt) Derivados de piperidina
AR050010A1 (es) Acido hialuronico reticulado soluble en agua, su procedimiento de preparacion, implanto que contiene dicho acido hialuronico reticulado, y su utilizacion
BR0213298A (pt) formulações com alta concentração de proteìna e processo de fabricação
IT1306643B1 (it) Processo per la preparazione dei composti autoreticolati dell'acidoialuronico e dei suoi derivati ottenibili mediante la tecnica
DK0387821T3 (da) 2-Alkyl-4-arylmethylchinoliner, deres anvendelse og lægemidler fremstillet hermed
AR018179A1 (es) Un proceso para la preparacion de preparaciones farmaceuticas que comprenden carvedilol o 4-[2-hidroxi-3-[ 4-fenoximetil)piperidino]-propoxi]-indol
NO20021337D0 (no) 4-benzylaminoquinolinkonjugater med gallesyre og deres heteroanaloger, fremgangsmåte for deres fremstilling, legemidlersom inneholder disse forbindelser og deres anvendelse
BRPI0516134A (pt) neurotoxinas de clostridium para uso na cicatrização de tecidos
DE60004204D1 (de) Pharmazeutische zusammensetzungen, bestimmt zur oralen verabreichung von phloroglucinol sowie deren herstellung
DE60032372D1 (de) Arzneizubereitungen enthaltend paclitaxel eingeschlossen in nanopartikeln von polymerischen mizellen
SE0203313D0 (sv) Behållare med syrabarriär och användning därav
DK1231908T3 (da) Farmaceutisk præparat, der omfatter en NO-donorforbindelse samt anvendelse heraf
PT1228031E (pt) Derivados do acido 15-hidroxieicosatetraenoico modificados na cadeia omega e sua utilizacao no tratamento da secura ocular
PT1232173E (pt) Derivados do acido fusidico